603 related articles for article (PubMed ID: 19100909)
1. mTOR-what does it do?
Hall MN
Transplant Proc; 2008 Dec; 40(10 Suppl):S5-8. PubMed ID: 19100909
[TBL] [Abstract][Full Text] [Related]
2. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.
Jacinto E; Loewith R; Schmidt A; Lin S; Rüegg MA; Hall A; Hall MN
Nat Cell Biol; 2004 Nov; 6(11):1122-8. PubMed ID: 15467718
[TBL] [Abstract][Full Text] [Related]
3. mTOR in aging, metabolism, and cancer.
Cornu M; Albert V; Hall MN
Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
[TBL] [Abstract][Full Text] [Related]
4. Complexity of the TOR signaling network.
Inoki K; Guan KL
Trends Cell Biol; 2006 Apr; 16(4):206-12. PubMed ID: 16516475
[TBL] [Abstract][Full Text] [Related]
5. Role of TSC-mTOR pathway in diabetic nephropathy.
Inoki K
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S59-62. PubMed ID: 18926585
[TBL] [Abstract][Full Text] [Related]
6. The expanding TOR signaling network.
Martin DE; Hall MN
Curr Opin Cell Biol; 2005 Apr; 17(2):158-66. PubMed ID: 15780592
[TBL] [Abstract][Full Text] [Related]
7. Growing roles for the mTOR pathway.
Sarbassov DD; Ali SM; Sabatini DM
Curr Opin Cell Biol; 2005 Dec; 17(6):596-603. PubMed ID: 16226444
[TBL] [Abstract][Full Text] [Related]
8. Growth control via TOR kinase signaling, an intracellular sensor of amino acid and energy availability, with crosstalk potential to proline metabolism.
Liao XH; Majithia A; Huang X; Kimmel AR
Amino Acids; 2008 Nov; 35(4):761-70. PubMed ID: 18651095
[TBL] [Abstract][Full Text] [Related]
9. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.
Avruch J; Hara K; Lin Y; Liu M; Long X; Ortiz-Vega S; Yonezawa K
Oncogene; 2006 Oct; 25(48):6361-72. PubMed ID: 17041622
[TBL] [Abstract][Full Text] [Related]
10. mTOR Signalling in Health and Disease.
Proud CG
Biochem Soc Trans; 2011 Apr; 39(2):431-6. PubMed ID: 21428914
[TBL] [Abstract][Full Text] [Related]
11. mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.
Wysocki PJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):231-41. PubMed ID: 19379082
[TBL] [Abstract][Full Text] [Related]
12. Cell growth control: little eukaryotes make big contributions.
De Virgilio C; Loewith R
Oncogene; 2006 Oct; 25(48):6392-415. PubMed ID: 17041625
[TBL] [Abstract][Full Text] [Related]
13. Activation of mTORC2 by association with the ribosome.
Zinzalla V; Stracka D; Oppliger W; Hall MN
Cell; 2011 Mar; 144(5):757-68. PubMed ID: 21376236
[TBL] [Abstract][Full Text] [Related]
14. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.
Yang X; Yang C; Farberman A; Rideout TC; de Lange CF; France J; Fan MZ
J Anim Sci; 2008 Apr; 86(14 Suppl):E36-50. PubMed ID: 17998426
[TBL] [Abstract][Full Text] [Related]
15. Nutritional control of cell growth via TOR signaling in budding yeast.
Wei Y; Zheng XF
Methods Mol Biol; 2011; 759():307-19. PubMed ID: 21863495
[TBL] [Abstract][Full Text] [Related]
16. TOR signaling in invertebrates.
Soulard A; Cohen A; Hall MN
Curr Opin Cell Biol; 2009 Dec; 21(6):825-36. PubMed ID: 19767189
[TBL] [Abstract][Full Text] [Related]
17. TORC1 of fission yeast is rapamycin-sensitive.
Takahara T; Maeda T
Genes Cells; 2012 Aug; 17(8):698-708. PubMed ID: 22762302
[TBL] [Abstract][Full Text] [Related]
18. [mTOR inhibitors: pleiotropic antiproliferative drugs].
Pallet N; Beaune P; Thervet E; Legendre C; Anglicheau D
Med Sci (Paris); 2006 Nov; 22(11):947-52. PubMed ID: 17101096
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin and the kidney. I. The signaling pathway.
Lieberthal W; Levine JS
Am J Physiol Renal Physiol; 2012 Jul; 303(1):F1-10. PubMed ID: 22419691
[TBL] [Abstract][Full Text] [Related]
20. Evolutionarily conserved regulation of TOR signalling.
Takahara T; Maeda T
J Biochem; 2013 Jul; 154(1):1-10. PubMed ID: 23698095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
